Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat in Anemia Due to Lower-Risk MDS With High Transfusion Burden
NCT07722988Phase 3Not yet recruiting
- Sponsor
- Kyntra Bio
- Start
- Apr 2027
- Primary completion
- Sep 2030
01
Overview
A Phase 3 trial of roxadustat in anemia, sponsored by Kyntra Bio. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07722988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07722988.